enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. AstraZeneca's Imfinzi gets FDA priority review for type of ...

   www.aol.com/news/astrazenecas-imfinzi-gets-fda...

   AstraZeneca said Imfinzi was also recently granted Breakthrough Therapy Designation by the FDA in the same setting, which will help accelerate the regulatory review. Small cell lung cancer is a ...

3. AstraZeneca's Investigational Cancer Drug Disappoints In Late ...

   www.aol.com/astrazenecas-investigational-cancer...

   At the World Conference on Lung Cancer (WCLC), the British pharma giant shared results from the NeoCOAST-2 Phase 2 platform trial of Imfinzi (durvalumab) in multiple combinations, before and after ...

4. AstraZeneca stock drops after lung cancer drug trial setback

   www.aol.com/news/astrazeneca-shares-drop-lung...

   (Reuters) -London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that its experimental precision drug did not significantly ...

5. US FDA approves AstraZeneca's non-small cell lung cancer ...

   www.aol.com/news/us-fda-approves-astrazenecas...

   Earlier today, the company received a priority review from the FDA for the use of Imfinzi in patients with limited-stage small cell lung cancer, causing shares to hit a record high of 130.48 ...

6. Saracatinib - Wikipedia

   en.wikipedia.org/wiki/Saracatinib

   Saracatinib (AZD-0530) is an experimental drug being developed by AstraZeneca. It acts as a dual kinase inhibitor, with selective actions as a Src inhibitor and a Bcr-Abl tyrosine-kinase inhibitor. [1] [2]

7. AstraZeneca says lung cancer drug trial shows no significant ...

   www.aol.com/news/astrazeneca-says-lung-cancer...

   The trial compared the two treatments -- AstraZeneca's drug and chemotherapy -- of patients whose non-small cell lung cancer had returned after one or two prior treatment attempts.

8. AstraZeneca's Tagrisso slashes death risk in certain post ...

   www.aol.com/news/astrazenecas-tagrisso-slashes...

   AstraZeneca's lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically ...

9. AstraZeneca's Imfinzi fails in late-stage trial to treat ...

   www.aol.com/news/astrazenecas-imfinzi-fails...

   The trial, known as ADJUVANT BR.31 Phase III, sought to evaluate Imfinzi in the adjuvant treatment of 1,415 patients with an early stage of non-small-cell lung cancer following complete tumour ...